Skip to content

Melodic Intonation Therapy in the Persian Autistic Children

The effects of melodic intonation therapy in decreasing autistic symptoms on 7-10 year old Persian male children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013091614684N1
Enrollment
13
Registered
2013-11-16
Start date
2011-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism. Pervasive developmental disorders. Childhood autism A type of pervasive developmental disorder that is defined by: (a) the presence of abnormal or impaired development that is manifest before the age of three years, and (b) the characteristic type of abno

Interventions

Intervention: Melodic Intonation Therapy ( Speech Therapy). Each participant will observe as his control. A single-subject design..
Rehabilitation
Intervention: Melodic Intonation Therapy ( Speech Therapy). Each participant will observe as his control. A single-subject design.

Sponsors

Vice chancellor for research, Payame Noor University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
7 Years to 10 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male; 7-10 years; Monolingual; Persian speaker; Right-handed; With a diagnosis of autism (diagnosis made by pediatric neurologists or psycho-neurologist prior to enrollment; Without major medical conditions such as motor disabilities (e.g., cerebral palsy or tuberous sclerosis), Sensory disabilities (e.g., blindness or deafness), Genetic disorders (e.g., Down Syndrome) other than ASD; Previously received speech therapy at least 12 months; Receptive language skills of >20 months, based on the Newsha developmental scale(Persian); The ability to sit in a chair for more than 15 minutes; follow one-step commands without prompting; and imitate simple gross motor and oral motor movements such as clapping their hands; stomping their feet, and opening their mouth. exclusion criteria: New interventions based on prescription of child's physician.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Echolalia. Timepoint: Before MIT(T1), After MIT(T2) (4 months after T1). Method of measurement: Record of Speech, Phonetic Transcription, Morpheme Count, Calculating echolalia percentage in speech output.;Mean Length of Utterance (MLU). Timepoint: Before MIT(T1), After MIT(T2) (4 months after T1). Method of measurement: Record of Speech, Phonetic Transcription, Morpheme Count, It is calculated by collecting 100 utterances spoken by a child and dividing the number of morphemes by the number of utterances.;Speech Rate. Timepoint: Before MIT(T1), After MIT(T2) (4 months after T1). Method of measurement: Record of Speech, Calculating word per minute in speech output.;Verb number average in sentence. Timepoint: Before MIT(T1), After MIT(T2) (4 months after T1). Method of measurement: Record of Speech, It is calculated by collecting the utterances spoken by a child and dividing the number of verbs by the number of utterances in speech output.

Secondary

MeasureTime frame
Vowel frequency. Timepoint: Before MIT(T1), after MIT(T2) 4 months after T1. Method of measurement: Record of single vowels, assessing fundamental frequency by using Praat software of acoustic phonetics.;Vowel Intensity. Timepoint: Before MIT(T1), after MIT(T2) 4 months after T1. Method of measurement: Record of single vowels, assessing intensity by using Praat software of acoustic phonetics.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Ashayeri

Iran University of Medical Sciences

ashayerih.neuroscientist@yahoo.com+98 21 2222 1577

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026